NHS to initiate COVID-19 vaccine distribution by the end of November
Category: #headlines  By Nikita Chaurasia  Date: 2020-11-09
  • share
  • Twitter
  • Facebook
  • LinkedIn

NHS to initiate COVID-19 vaccine distribution by the end of November

 

  • The vaccine will be first delivered to homecare residents, frontline healthcare professionals and people over 80 years.
  • Reportedly, doctors would be paid £12.58 for each dosage of the vaccine

According to reliable sources, the publicly funded healthcare system of the United Kingdom, National Health Service (NHS) is reportedly planning a mass distribution of COVID-19 vaccines towards the end of November. The vaccination will be administered in two doses, making sure they are given with an interval of three to four weeks.

If reports are to be believed, the vaccines would be made available primarily for homecare residents, frontline healthcare professionals and people over the age of 80 years. Among these, the care home residents will be given the highest priority as they account for around 40% of the Coronavirus-related deaths in the United Kingdom.

Sources close to the matter claimed that the NHS has allocated two London hospitals, namely King's College Hospital and St. Thomas Hospital, as the focal point for the distribution and administration of the vaccine. The staff employed to carry out these operations will be known as “vaccine task forces”.

In a meeting with executives and senior managers, Jon Findlay, head of Guy’s and St Thomas’ NHS Foundation Trust, reportedly mentioned that a COVID-19 vaccine could be made available for distribution as well as administration by the end of November.

As per credible sources, doctors would be paid £12.58 for each dosage of the vaccine. Additionally, the U.K. government has made plans to purchase 350 million doses of the 6 contrasting vaccines that are currently being developed.

In other news, President of Argentina, Alberto Fernandes has reportedly stated that the country is expected to receive around 750,000 doses of a potential COVID-10 vaccine from U.S.-based multinational pharmaceutical company, Pfizer Inc. by December 2020.

Source credits: https://www.express.co.uk/news/uk/1357805/coronavirus-vaccine-news-uk-latest-covid19-vaccine-uk-nhs-hospitals-boris-johnson-matt-han

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Nikita Chaurasia    

Nikita Chaurasia

Having always been daft at wordplay, Nikita Chaurasia, post the completion of post-graduation, commenced her journey into the content generation cosmos. Endowed with a professional MBA degree in Advertising and Public Relations, Nikita strives to integrate her creativ...

Read More

More News By Nikita Chaurasia

Syndax Pharmaceuticals reveals data from phase 1 trial of axatilimab
Syndax Pharmaceuticals reveals data from phase 1 trial of axatilimab
By Nikita Chaurasia

According to reliable sources, Massachusetts-headquartered clinical stage biopharmaceutical company, Syndax Pharmaceuticals Inc. has revealed an updated data from its Phase 1 trial of its patent axatilimab. The company will reportedly present the dat...

Xiaomi shares drop by 7.1% after raising USD 3.9 billion in equity deal
Xiaomi shares drop by 7.1% after raising USD 3.9 billion in equity deal
By Nikita Chaurasia

Shares of Xiaomi Corporation, a Chinese multinational electronics company, witnessed a 7.1% drop during Hong Kong trading after the company secured USD 3.91 billion in fund raising which also included the city’s top-up placement. The company h...

Supercom signs a supply contract of PureSecurity EM suite in Wisconsin
Supercom signs a supply contract of PureSecurity EM suite in Wisconsin
By Nikita Chaurasia

Israel-based leading provider of advanced solutions for cybersecurity, IoT (Internet of Things) and e-Government sectors Supercom has reportedly signed a supply agreement to deliver its PureSecurity EM (Electronic Monitoring) product suite in Wiscons...